Working at the interface of material science, chemistry, biology, and biomedical engineering, we aim to advance gene therapies for CNS diseases and aging by engineering novel non-viral vectors and biomaterials.

 

Our research focuses on bypassing the blood-brain barrier to achieve regional targeting and cell-specific delivery. Applications include gene therapies for stroke, traumatic brain injury, neuroinflammation, and neurodegeneration.

​

** Recruiting a PhD student with an organic synthesis background in small molecules or polymers for the 2027  Fall.